Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Clinical trial NCT01547741 · COMPLETED
Trial details
- NCT number
- NCT01547741
- Sponsor
- NSABP Foundation Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2022-05-31
- Enrollment
- 4242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.